Bone morphogenetic protein 8a (BMP8A)

Bone morphogenetic protein 8a (BMP8A) is a secreted cytokine and growth factor belonging to the TGF-β superfamily. BMP8A initiates canonical BMP signaling by binding heteromeric complexes of type I (BMPR1A) and type II (BMPR2) receptors, resulting in activation of SMAD transcription factors and regulation of diverse gene sets governing bone formation, cartilage induction, and reproductive tissue development. BMP8A also influences energy balance, acting in the hypothalamus and peripheral tissues to regulate brown fat thermogenesis. Although diseases directly linked to BMP8A are rare, its functional roles make it an experimental target in bone biology and metabolic research. The protein forms cystine-knot structure dimers typical of the BMP family and is characterized by cytokine and growth factor activity within the extracellular compartment.

Other names

BMP8ABone morphogenetic protein 8aBMP-8a (hyphenated form is occasionally used in literature)Sometimes just "BMP8" in older sources or cross-species references

Experimental BMP pathway antagonists typically inhibit ligand–receptor interaction, block receptor activation, or interfere with SMAD phosphorylation/transcriptional activity. In principle, drugs targeting BMP8A would modulate its signaling cascade—e.g., inhibitor of BMP8A would reduce activation of SMAD1/5/8 and downstream gene transcription. No BMP8A-selective drugs are known.